These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19883753)

  • 1. Inflammation in transgenic mouse models of neurodegenerative disorders.
    Schwab C; Klegeris A; McGeer PL
    Biochim Biophys Acta; 2010 Oct; 1802(10):889-902. PubMed ID: 19883753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic mouse models of neurodegenerative diseases.
    Trancikova A; Ramonet D; Moore DJ
    Prog Mol Biol Transl Sci; 2011; 100():419-82. PubMed ID: 21377633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic nonhuman primates for neurodegenerative diseases.
    Chan AW
    Reprod Biol Endocrinol; 2004 Jun; 2():39. PubMed ID: 15200672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases.
    Walker DG; Lue LF
    J Neurosci Res; 2005 Aug; 81(3):412-25. PubMed ID: 15957156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane-type 1 metalloproteinase is upregulated in microglia/brain macrophages in neurodegenerative and neuroinflammatory diseases.
    Langenfurth A; Rinnenthal JL; Vinnakota K; Prinz V; Carlo AS; Stadelmann C; Siffrin V; Peaschke S; Endres M; Heppner F; Glass R; Wolf SA; Kettenmann H
    J Neurosci Res; 2014 Mar; 92(3):275-86. PubMed ID: 24323769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Immunity and Inflammation in the Pathophysiology of Neurodegenerative Diseases.
    Fakhoury M
    Neurodegener Dis; 2015; 15(2):63-9. PubMed ID: 25591815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodegenerative diseases: The immunological perspective.
    Molteni M; Rossetti C
    J Neuroimmunol; 2017 Dec; 313():109-115. PubMed ID: 29153601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent systemic infections with Streptococcus pneumoniae do not aggravate the course of experimental neurodegenerative diseases.
    Ebert S; Goos M; Rollwagen L; Baake D; Zech WD; Esselmann H; Wiltfang J; Mollenhauer B; Schliebs R; Gerber J; Nau R
    J Neurosci Res; 2010 Apr; 88(5):1124-36. PubMed ID: 19859962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral phenotyping of mouse models of neurodegeneration.
    Dumont M
    Methods Mol Biol; 2011; 793():229-37. PubMed ID: 21913104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microglial cells in neurodegenerative disorders.
    Wojtera M; Sikorska B; Sobow T; Liberski PP
    Folia Neuropathol; 2005; 43(4):311-21. PubMed ID: 16416395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of complement in neurodegeneration and neuroinflammation.
    Bonifati DM; Kishore U
    Mol Immunol; 2007 Feb; 44(5):999-1010. PubMed ID: 16698083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic animal models of neurodegenerative diseases and their application to treatment development.
    Rockenstein E; Crews L; Masliah E
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1093-102. PubMed ID: 17869376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of MRS to mouse models of neurodegenerative illness.
    Choi JK; Dedeoglu A; Jenkins BG
    NMR Biomed; 2007 May; 20(3):216-37. PubMed ID: 17451183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of Disease: astrocytes in neurodegenerative disease.
    Maragakis NJ; Rothstein JD
    Nat Clin Pract Neurol; 2006 Dec; 2(12):679-89. PubMed ID: 17117171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal delivery of bone marrow-derived mesenchymal stem cells, macrophages, and microglia to the brain in mouse models of Alzheimer's and Parkinson's disease.
    Danielyan L; Beer-Hammer S; Stolzing A; Schäfer R; Siegel G; Fabian C; Kahle P; Biedermann T; Lourhmati A; Buadze M; Novakovic A; Proksch B; Gleiter CH; Frey WH; Schwab M
    Cell Transplant; 2014; 23 Suppl 1():S123-39. PubMed ID: 25302802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Searching for new animal models of Alzheimer's disease.
    Epis R; Gardoni F; Marcello E; Genazzani A; Canonico PL; Di Luca M
    Eur J Pharmacol; 2010 Jan; 626(1):57-63. PubMed ID: 19836370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global changes to the ubiquitin system in Huntington's disease.
    Bennett EJ; Shaler TA; Woodman B; Ryu KY; Zaitseva TS; Becker CH; Bates GP; Schulman H; Kopito RR
    Nature; 2007 Aug; 448(7154):704-8. PubMed ID: 17687326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein aggregate characterization in models of neurodegenerative disease.
    Tebbenkamp AT; Borchelt DR
    Methods Mol Biol; 2009; 566():85-91. PubMed ID: 20058166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What transgenic mice tell us about neurodegenerative disease.
    Gurney ME
    Bioessays; 2000 Mar; 22(3):297-304. PubMed ID: 10684590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling neurodegenerative diseases in Caenorhabditis elegans.
    Li J; Le W
    Exp Neurol; 2013 Dec; 250():94-103. PubMed ID: 24095843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.